Accessibility Tools

Skip to main content

Department of Neuropeptides


Head
Piotr Lipiński, PhD, MPharm, email This email address is being protected from spambots. You need JavaScript enabled to view it., phone: +48 22 60 86 480

Research staff
Prof. Aleksandra Misicka-Kęsik, DSc, PhD email: This email address is being protected from spambots. You need JavaScript enabled to view it., phone: +48 22 60 86 454
Jolanta Dyniewicz, PhD, email: This email address is being protected from spambots. You need JavaScript enabled to view it., phone: +48 22 60 86 480
Piotr Kosson, VD, PhD, email: This email address is being protected from spambots. You need JavaScript enabled to view it., phone: +48 22 60 86 454
Joanna Matalińska, PhD, email: This email address is being protected from spambots. You need JavaScript enabled to view it., phone: +48 22 60 86 455/548
Patrycja Redkiewicz, PhD, email: This email address is being protected from spambots. You need JavaScript enabled to view it., phone: +48 22 60 86 480
PhD students
Katarzyna Kosińska, MSc email: This email address is being protected from spambots. You need JavaScript enabled to view it. , phone: +48 60 86 480

Research profile
• Search for novel analgesic substances for the treatment of acute, chronic and neuropathic pain.
• Search for novel active substances with anticancer activity.

Grants
• Radiopharmaceuticals based on neurokinin-1 receptor antagonists for the diagnosis and therapy of a brain tumour - glioblastoma multiforme, 2017/25/B/NZ7/01896, led by prof. Aleksandra Misicka-Kęsik, 2018-2021.
• Development of an NK1 receptor homology model based on the data concerning interspecies differences in ligand binding, 2016/23/D/NZ7/0363, led by Piotr F.J. Lipiński, 2017-2021.

Collaboration
domestic

• Faculty of Chemistry, University of Warsaw, Warsaw
• Institute of Nuclear Chemistry and Technology, Warsaw
• National Medicines Institute, Warsaw
• Medical University of Lodz, Lodz
• Maj Institute of Pharmacology Polish Academy of Sciences, Cracow
foreign
• Biological Research Institute, Hungarian Academy of Sciences, Szeged, Hungary
• University of Arizona, Tucson, USA

Research equipment
• Preparative HPLC setup (Shimadzu)
• HPLC setup coupled to mass spectrometry (LC-MS, Shimadzu)
• 96-well harvester, Microbeta Filtermat (Perkin Elmer)
• 24-well harvester, M-24 Cell Harvester (Brandel)
• Scintillation/luminescence counter (1450 LSC & Luminescence Counter, Wallac MicroBeta TriLux, Perkin Elmer)

Research methods
• Organic synthesis (peptides and peptidomimetics)
• Receptor binding assays with radiometric methods
• In vitro assessment of cytotoxic and antiproliferative activity
• In vivo testing of antinociceptive activity in acute and chronic pain models
• Molecular modelling of ligand-receptor interactions (docking, molecular dynamics)

Selected publications

  • Halik, P.J.; Lipiński, P.F.J.; Matalińska, J.; Koźmiński, P.; Misicka, A.; Gniazdowska, E. Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors, Molecules, 2020, 25 3756. 
  • Dyniewicz, J.; Lipiński, P.F.J.; Kosson, P.; Bochyńska-Czyż, M.; Matalińska, J.; Misicka, A. Antinociceptive and cytotoxic activity of opioid peptides with hydrazone and hydrazide moieties at the C-terminus, Molecules, 2020, 25, 3429.
  • Kowalczyk, A.; Lipiński, P.F.J.; Karoń, K.; Rode, J.E.; Lyczko, K.; Dobrowolski, J.Cz.; Donten, M.; Kaczorek, D.; Poszytek, J.; Kawęcki, R.; Łapkowski, M.; Malkowska, A.; Grudziński, I.P.; Nowicka, A.M. Enantioselective sensing of (S)-Thalidomide in blood plasma with a chiral naphthalene diimide derivative, Biosens Bioelectron, 2020, 167, 112446.
  • Matalińska J.; Lipiński P.F.J.; Kotlarz A.; Misicka A. Antiproliferative effects of [D-Pro2, D-Trp7,9]-substance P and aprepitant on several cancer cell lines and their selectivity in comparison to normal cells, Folia Neuropathol, 2020, 3, in press.
  • Tymecka, D., Lipiński, P.F.J.; Kosson, P.; Misicka, A. beta2-Homo-Amino Acid Scan of Mu-Selective Opioid Tetrapeptide TAPP, Molecules, 2020, 25, 2461
  • Adamska-Bartłomiejczyk, A.; Lipiński P.F.J.; Piekielna-Ciesielska, J.; Kluczyk, A.; Janecka, A Pharmacological profile and molecular modeling of cyclic opioid analogs incorporating various phenylalanine derivatives, ChemMedChem, 2020, 15.
  • Kokocinska-Kusiak, A.; Matalińska, J.; Sacharczuk, M.; Sobczyńska, M.; Góral-Radziszewska, K.; Wileńska, B.; Misicka, A.; Jezierski, T. Can mice be trained to discriminate urine odor of conspecifics with melanoma before clinical symptoms appear? J Vet Beh 2020 doi: 10.1016/j.jveb.2020.04.004
  • Bochynska-Czyz, M.; Redkiewicz, P.; Kozlowska, H.; Matalinska, J.; Konop, M.; Kosson, P. Can keratin scaffolds be used for creating three-dimensional cell cultures? Open Medicine, 2020 15, 249 DOI: 10.1515/med-2020-0031
  • Matalińska, J.; Lipiński, P.F.J.; Kotlarz, A.; Kosson, P.; Muchowska, A.; Dyniewicz, J. Evaluation of Receptor Affinity, Analgesic Activity and Cytotoxicity of a Hybrid Peptide, AWL3020. Int J Pept Res Ther. 2020. doi:10.1007/s10989-020-10051-5
  • Fedorczyk, B.; Lipiński, P.F.J.; Puszko, A.K.; Tymecka, D.; Wilenska, B.; Dudka, W.; Perret, G.Y.; Wieczorek, R.; Misicka, A. Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165. Molecules 2019, 24, 1756.
  • Lipiński, P.; Kosson, P.; Matalińska, J.; Roszkowski, P.; Czarnocki, Z.; Jarończyk, M.; Misicka, A.; Dobrowolski, J.; Sadlej, J. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis. Molecules 2019, 24, 740.
  • Lipiński, P.F.J.; Szűcs, E.; Jarończyk, M.; Kosson, P.; Benyhe, S.; Misicka, A.; Dobrowolski, J.C.; Sadlej, J. Affinity of fentanyl and its derivatives for the σ 1 -receptor. Medchemcomm 2019, 10, 1187.
  • Lipiński, P.F.J.; Jarończyk, M.; Dobrowolski, J.C.; Sadlej, J. Molecular dynamics of fentanyl bound to μ-opioid receptor. J. Mol. Model. 2019, 25, 144.
  • Wilenska, B.; Tymecka, D.; Włodarczyk, M.; Sobolewska-Włodarczyk, A.; Wiśniewska-Jarosińska, M.; Dyniewicz, J.; Somogyi, Á.; Fichna, J.; Misicka, A. Enkephalin degradation in serum of patients with inflammatoryboweldiseases. Pharmacol. Reports 2019, 71, 42.
  • Zatorski, H.; Salaga, M.; Zielińska, M.; Wasilewski, A.; Misicka, A.; Sacharczuk, M.; Fichna, J. High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury. Pharmacol. Reports 2019, 71, 218.
  • Puszko, A.K.; Sosnowski, P.; Pułka-Ziach, K.; Hermine, O.; Hopfgartner, G.; Lepelletier, Y.; Misicka, A. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complex. Bioorg. Med. Chem. Lett. 2019, 29, 2493.
  • Puszko, A.K.; Sosnowski, P.; Tymecka, D.; Raynaud, F.; Hermine, O.; Lepelletier, Y.; Misicka, A. Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method. Medchemcomm 2019, 10, 332.
  • Sowinska, M.; Morawiak, M.; Bochyńska-Czyż, M.; Lipkowski, A.; Ziemińska, E.; Zabłocka, B.; Urbanczyk-Lipkowska, Z. Molecular Antioxidant Properties and In Vitro Cell Toxicity of the p-AminobenzoicAcid (PABA) Functionalized Peptide Dendrimers. Biomolecules 2019, 9, 89.
  • Ciechanowicz, P.; Rakowska, A.; Sikora, M.; Rudnicka, L. JAK-inhibitors in dermatology: current evidence and future applications. J. Dermatolog. Treat. 2019, 30, 648.
  • Muchowska, A.; Redkiewicz, P., Różycki K., Matalińska J.; Lipiński PFJ.; Czuwara J.; Kosson P. The analgesic hybrid of dermorphin/substance P and analog of enkephalin improve wound healing in streptozotocin-induced diabetic rats. WoundRepair Regen. 2019, doi:10.1111/wrr.12775.
  • Konop, M.; Kłodzińska E.; Borowiec J.; Laskowska AK.; Czuwara J; Konieczka P.; Cieślik B.; Waraksa E.; Rudnicka L. Application of micellar electrokinetic chromatography for detection of silver nanoparticles released from wound dressing. 2019, 40, 1565.
Contact Details

Mossakowski Medical Research Institute
Polish Academy of Sciences
5 Pawinskiego Str., 02-106 Warsaw, Poland

© All rights reserved.
Designed and implemented by WINDWEB.